Capital Advisors, Ltd. LLC Keros Therapeutics, Inc. Transaction History
Capital Advisors, Ltd. LLC
- $759 Million
- Q1 2025
A detailed history of Capital Advisors, Ltd. LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 16 shares of KROS stock, worth $231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$231% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KROS
# of Institutions
173Shares Held
30.6MCall Options Held
646KPut Options Held
670K-
Black Rock Inc. New York, NY2.51MShares$36.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$28.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$27.4 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$24.4 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$17.4 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $372M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...